Global Viral Gene Therapy Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Viral Gene Therapy Market Size 2017-2028

2.1.2 Viral Gene Therapy Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Viral Gene Therapy Segment by Type

2.2.1 Integrating Viral Vectors

2.2.2 Non-Integrating Viral Vectors

2.3 Viral Gene Therapy Market Size by Type

2.3.1 Viral Gene Therapy Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Viral Gene Therapy Market Size Market Share by Type (2017-2022)

2.4 Viral Gene Therapy Segment by Application

2.4.1 Metabolic Diseases

2.4.2 Cardiovascular Diseases

2.4.3 Muscular Diseases

2.4.4 Hematologic Diseases

2.4.5 Ophthalmologic Diseases

2.4.6 Infectious Diseases

2.4.7 Others

2.5 Viral Gene Therapy Market Size by Application

2.5.1 Viral Gene Therapy Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Viral Gene Therapy Market Size Market Share by Application (2017-2022)

3 Viral Gene Therapy Market Size by Player

3.1 Viral Gene Therapy Market Size Market Share by Players

3.1.1 Global Viral Gene Therapy Revenue by Players (2020-2022)

3.1.2 Global Viral Gene Therapy Revenue Market Share by Players (2020-2022)

3.2 Global Viral Gene Therapy Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Viral Gene Therapy by Regions

4.1 Viral Gene Therapy Market Size by Regions (2017-2022)

4.2 Americas Viral Gene Therapy Market Size Growth (2017-2022)

4.3 APAC Viral Gene Therapy Market Size Growth (2017-2022)

4.4 Europe Viral Gene Therapy Market Size Growth (2017-2022)

4.5 Middle East & Africa Viral Gene Therapy Market Size Growth (2017-2022)

5 Americas

5.1 Americas Viral Gene Therapy Market Size by Country (2017-2022)

5.2 Americas Viral Gene Therapy Market Size by Type (2017-2022)

5.3 Americas Viral Gene Therapy Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Viral Gene Therapy Market Size by Region (2017-2022)

6.2 APAC Viral Gene Therapy Market Size by Type (2017-2022)

6.3 APAC Viral Gene Therapy Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Viral Gene Therapy by Country (2017-2022)

7.2 Europe Viral Gene Therapy Market Size by Type (2017-2022)

7.3 Europe Viral Gene Therapy Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Viral Gene Therapy by Region (2017-2022)

8.2 Middle East & Africa Viral Gene Therapy Market Size by Type (2017-2022)

8.3 Middle East & Africa Viral Gene Therapy Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Viral Gene Therapy Market Forecast

10.1 Global Viral Gene Therapy Forecast by Regions (2023-2028)

10.1.1 Global Viral Gene Therapy Forecast by Regions (2023-2028)

10.1.2 Americas Viral Gene Therapy Forecast

10.1.3 APAC Viral Gene Therapy Forecast

10.1.4 Europe Viral Gene Therapy Forecast

10.1.5 Middle East & Africa Viral Gene Therapy Forecast

10.2 Americas Viral Gene Therapy Forecast by Country (2023-2028)

10.2.1 United States Viral Gene Therapy Market Forecast

10.2.2 Canada Viral Gene Therapy Market Forecast

10.2.3 Mexico Viral Gene Therapy Market Forecast

10.2.4 Brazil Viral Gene Therapy Market Forecast

10.3 APAC Viral Gene Therapy Forecast by Region (2023-2028)

10.3.1 China Viral Gene Therapy Market Forecast

10.3.2 Japan Viral Gene Therapy Market Forecast

10.3.3 Korea Viral Gene Therapy Market Forecast

10.3.4 Southeast Asia Viral Gene Therapy Market Forecast

10.3.5 India Viral Gene Therapy Market Forecast

10.3.6 Australia Viral Gene Therapy Market Forecast

10.4 Europe Viral Gene Therapy Forecast by Country (2023-2028)

10.4.1 Germany Viral Gene Therapy Market Forecast

10.4.2 France Viral Gene Therapy Market Forecast

10.4.3 UK Viral Gene Therapy Market Forecast

10.4.4 Italy Viral Gene Therapy Market Forecast

10.4.5 Russia Viral Gene Therapy Market Forecast

10.5 Middle East & Africa Viral Gene Therapy Forecast by Region (2023-2028)

10.5.1 Egypt Viral Gene Therapy Market Forecast

10.5.2 South Africa Viral Gene Therapy Market Forecast

10.5.3 Israel Viral Gene Therapy Market Forecast

10.5.4 Turkey Viral Gene Therapy Market Forecast

10.5.5 GCC Countries Viral Gene Therapy Market Forecast

10.6 Global Viral Gene Therapy Forecast by Type (2023-2028)

10.7 Global Viral Gene Therapy Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Lonza

11.1.1 Lonza Company Information

11.1.2 Lonza Viral Gene Therapy Product Offered

11.1.3 Lonza Viral Gene Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Lonza Main Business Overview

11.1.5 Lonza Latest Developments

11.2 Biogen

11.2.1 Biogen Company Information

11.2.2 Biogen Viral Gene Therapy Product Offered

11.2.3 Biogen Viral Gene Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Biogen Main Business Overview

11.2.5 Biogen Latest Developments

11.3 Catalent

11.3.1 Catalent Company Information

11.3.2 Catalent Viral Gene Therapy Product Offered

11.3.3 Catalent Viral Gene Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Catalent Main Business Overview

11.3.5 Catalent Latest Developments

11.4 Gilead Sciences

11.4.1 Gilead Sciences Company Information

11.4.2 Gilead Sciences Viral Gene Therapy Product Offered

11.4.3 Gilead Sciences Viral Gene Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Gilead Sciences Main Business Overview

11.4.5 Gilead Sciences Latest Developments

11.5 Sarepta Therapeutics

11.5.1 Sarepta Therapeutics Company Information

11.5.2 Sarepta Therapeutics Viral Gene Therapy Product Offered

11.5.3 Sarepta Therapeutics Viral Gene Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Sarepta Therapeutics Main Business Overview

11.5.5 Sarepta Therapeutics Latest Developments

11.6 Novartis

11.6.1 Novartis Company Information

11.6.2 Novartis Viral Gene Therapy Product Offered

11.6.3 Novartis Viral Gene Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Novartis Main Business Overview

11.6.5 Novartis Latest Developments

11.7 Amgen

11.7.1 Amgen Company Information

11.7.2 Amgen Viral Gene Therapy Product Offered

11.7.3 Amgen Viral Gene Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Amgen Main Business Overview

11.7.5 Amgen Latest Developments

11.8 Ionis Pharmaceuticals

11.8.1 Ionis Pharmaceuticals Company Information

11.8.2 Ionis Pharmaceuticals Viral Gene Therapy Product Offered

11.8.3 Ionis Pharmaceuticals Viral Gene Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Ionis Pharmaceuticals Main Business Overview

11.8.5 Ionis Pharmaceuticals Latest Developments

11.9 Spark Therapeutics

11.9.1 Spark Therapeutics Company Information

11.9.2 Spark Therapeutics Viral Gene Therapy Product Offered

11.9.3 Spark Therapeutics Viral Gene Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Spark Therapeutics Main Business Overview

11.9.5 Spark Therapeutics Latest Developments

11.10 Shanghai Sunway Biotech

11.10.1 Shanghai Sunway Biotech Company Information

11.10.2 Shanghai Sunway Biotech Viral Gene Therapy Product Offered

11.10.3 Shanghai Sunway Biotech Viral Gene Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Shanghai Sunway Biotech Main Business Overview

11.10.5 Shanghai Sunway Biotech Latest Developments

11.11 SIBIONO

11.11.1 SIBIONO Company Information

11.11.2 SIBIONO Viral Gene Therapy Product Offered

11.11.3 SIBIONO Viral Gene Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 SIBIONO Main Business Overview

11.11.5 SIBIONO Latest Developments

11.12 AnGes

11.12.1 AnGes Company Information

11.12.2 AnGes Viral Gene Therapy Product Offered

11.12.3 AnGes Viral Gene Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 AnGes Main Business Overview

11.12.5 AnGes Latest Developments

11.13 Orchard Therapeutics

11.13.1 Orchard Therapeutics Company Information

11.13.2 Orchard Therapeutics Viral Gene Therapy Product Offered

11.13.3 Orchard Therapeutics Viral Gene Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.13.4 Orchard Therapeutics Main Business Overview

11.13.5 Orchard Therapeutics Latest Developments

12 Research Findings and Conclusion

Table 1. Viral Gene Therapy Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Integrating Viral Vectors

Table 3. Major Players of Non-Integrating Viral Vectors

Table 4. Viral Gene Therapy Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 5. Global Viral Gene Therapy Market Size by Type (2017-2022) & ($ Millions)

Table 6. Global Viral Gene Therapy Market Size Market Share by Type (2017-2022)

Table 7. Viral Gene Therapy Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 8. Global Viral Gene Therapy Market Size by Application (2017-2022) & ($ Millions)

Table 9. Global Viral Gene Therapy Market Size Market Share by Application (2017-2022)

Table 10. Global Viral Gene Therapy Revenue by Players (2020-2022) & ($ Millions)

Table 11. Global Viral Gene Therapy Revenue Market Share by Player (2020-2022)

Table 12. Viral Gene Therapy Key Players Head office and Products Offered

Table 13. Viral Gene Therapy Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 14. New Products and Potential Entrants

Table 15. Mergers & Acquisitions, Expansion

Table 16. Global Viral Gene Therapy Market Size by Regions 2017-2022 & ($ Millions)

Table 17. Global Viral Gene Therapy Market Size Market Share by Regions (2017-2022)

Table 18. Americas Viral Gene Therapy Market Size by Country (2017-2022) & ($ Millions)

Table 19. Americas Viral Gene Therapy Market Size Market Share by Country (2017-2022)

Table 20. Americas Viral Gene Therapy Market Size by Type (2017-2022) & ($ Millions)

Table 21. Americas Viral Gene Therapy Market Size Market Share by Type (2017-2022)

Table 22. Americas Viral Gene Therapy Market Size by Application (2017-2022) & ($ Millions)

Table 23. Americas Viral Gene Therapy Market Size Market Share by Application (2017-2022)

Table 24. APAC Viral Gene Therapy Market Size by Region (2017-2022) & ($ Millions)

Table 25. APAC Viral Gene Therapy Market Size Market Share by Region (2017-2022)

Table 26. APAC Viral Gene Therapy Market Size by Type (2017-2022) & ($ Millions)

Table 27. APAC Viral Gene Therapy Market Size Market Share by Type (2017-2022)

Table 28. APAC Viral Gene Therapy Market Size by Application (2017-2022) & ($ Millions)

Table 29. APAC Viral Gene Therapy Market Size Market Share by Application (2017-2022)

Table 30. Europe Viral Gene Therapy Market Size by Country (2017-2022) & ($ Millions)

Table 31. Europe Viral Gene Therapy Market Size Market Share by Country (2017-2022)

Table 32. Europe Viral Gene Therapy Market Size by Type (2017-2022) & ($ Millions)

Table 33. Europe Viral Gene Therapy Market Size Market Share by Type (2017-2022)

Table 34. Europe Viral Gene Therapy Market Size by Application (2017-2022) & ($ Millions)

Table 35. Europe Viral Gene Therapy Market Size Market Share by Application (2017-2022)

Table 36. Middle East & Africa Viral Gene Therapy Market Size by Region (2017-2022) & ($ Millions)

Table 37. Middle East & Africa Viral Gene Therapy Market Size Market Share by Region (2017-2022)

Table 38. Middle East & Africa Viral Gene Therapy Market Size by Type (2017-2022) & ($ Millions)

Table 39. Middle East & Africa Viral Gene Therapy Market Size Market Share by Type (2017-2022)

Table 40. Middle East & Africa Viral Gene Therapy Market Size by Application (2017-2022) & ($ Millions)

Table 41. Middle East & Africa Viral Gene Therapy Market Size Market Share by Application (2017-2022)

Table 42. Key Market Drivers & Growth Opportunities of Viral Gene Therapy

Table 43. Key Market Challenges & Risks of Viral Gene Therapy

Table 44. Key Industry Trends of Viral Gene Therapy

Table 45. Global Viral Gene Therapy Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 46. Global Viral Gene Therapy Market Size Market Share Forecast by Regions (2023-2028)

Table 47. Global Viral Gene Therapy Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 48. Global Viral Gene Therapy Market Size Market Share Forecast by Type (2023-2028)

Table 49. Global Viral Gene Therapy Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 50. Global Viral Gene Therapy Market Size Market Share Forecast by Application (2023-2028)

Table 51. Lonza Details, Company Type, Viral Gene Therapy Area Served and Its Competitors

Table 52. Lonza Viral Gene Therapy Product Offered

Table 53. Lonza Viral Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 54. Lonza Main Business

Table 55. Lonza Latest Developments

Table 56. Biogen Details, Company Type, Viral Gene Therapy Area Served and Its Competitors

Table 57. Biogen Viral Gene Therapy Product Offered

Table 58. Biogen Main Business

Table 59. Biogen Viral Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 60. Biogen Latest Developments

Table 61. Catalent Details, Company Type, Viral Gene Therapy Area Served and Its Competitors

Table 62. Catalent Viral Gene Therapy Product Offered

Table 63. Catalent Main Business

Table 64. Catalent Viral Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 65. Catalent Latest Developments

Table 66. Gilead Sciences Details, Company Type, Viral Gene Therapy Area Served and Its Competitors

Table 67. Gilead Sciences Viral Gene Therapy Product Offered

Table 68. Gilead Sciences Main Business

Table 69. Gilead Sciences Viral Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 70. Gilead Sciences Latest Developments

Table 71. Sarepta Therapeutics Details, Company Type, Viral Gene Therapy Area Served and Its Competitors

Table 72. Sarepta Therapeutics Viral Gene Therapy Product Offered

Table 73. Sarepta Therapeutics Main Business

Table 74. Sarepta Therapeutics Viral Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 75. Sarepta Therapeutics Latest Developments

Table 76. Novartis Details, Company Type, Viral Gene Therapy Area Served and Its Competitors

Table 77. Novartis Viral Gene Therapy Product Offered

Table 78. Novartis Main Business

Table 79. Novartis Viral Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 80. Novartis Latest Developments

Table 81. Amgen Details, Company Type, Viral Gene Therapy Area Served and Its Competitors

Table 82. Amgen Viral Gene Therapy Product Offered

Table 83. Amgen Main Business

Table 84. Amgen Viral Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 85. Amgen Latest Developments

Table 86. Ionis Pharmaceuticals Details, Company Type, Viral Gene Therapy Area Served and Its Competitors

Table 87. Ionis Pharmaceuticals Viral Gene Therapy Product Offered

Table 88. Ionis Pharmaceuticals Main Business

Table 89. Ionis Pharmaceuticals Viral Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 90. Ionis Pharmaceuticals Latest Developments

Table 91. Spark Therapeutics Details, Company Type, Viral Gene Therapy Area Served and Its Competitors

Table 92. Spark Therapeutics Viral Gene Therapy Product Offered

Table 93. Spark Therapeutics Main Business

Table 94. Spark Therapeutics Viral Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 95. Spark Therapeutics Latest Developments

Table 96. Shanghai Sunway Biotech Details, Company Type, Viral Gene Therapy Area Served and Its Competitors

Table 97. Shanghai Sunway Biotech Viral Gene Therapy Product Offered

Table 98. Shanghai Sunway Biotech Main Business

Table 99. Shanghai Sunway Biotech Viral Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 100. Shanghai Sunway Biotech Latest Developments

Table 101. SIBIONO Details, Company Type, Viral Gene Therapy Area Served and Its Competitors

Table 102. SIBIONO Viral Gene Therapy Product Offered

Table 103. SIBIONO Viral Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 104. SIBIONO Main Business

Table 105. SIBIONO Latest Developments

Table 106. AnGes Details, Company Type, Viral Gene Therapy Area Served and Its Competitors

Table 107. AnGes Viral Gene Therapy Product Offered

Table 108. AnGes Main Business

Table 109. AnGes Viral Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 110. AnGes Latest Developments

Table 111. Orchard Therapeutics Details, Company Type, Viral Gene Therapy Area Served and Its Competitors

Table 112. Orchard Therapeutics Viral Gene Therapy Product Offered

Table 113. Orchard Therapeutics Main Business

Table 114. Orchard Therapeutics Viral Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 115. Orchard Therapeutics Latest Developments

List of Figures

Figure 1. Viral Gene Therapy Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Viral Gene Therapy Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Viral Gene Therapy Market Size Market Share by Type in 2021

Figure 7. Viral Gene Therapy in Metabolic Diseases

Figure 8. Global Viral Gene Therapy Market: Metabolic Diseases (2017-2022) & ($ Millions)

Figure 9. Viral Gene Therapy in Cardiovascular Diseases

Figure 10. Global Viral Gene Therapy Market: Cardiovascular Diseases (2017-2022) & ($ Millions)

Figure 11. Viral Gene Therapy in Muscular Diseases

Figure 12. Global Viral Gene Therapy Market: Muscular Diseases (2017-2022) & ($ Millions)

Figure 13. Viral Gene Therapy in Hematologic Diseases

Figure 14. Global Viral Gene Therapy Market: Hematologic Diseases (2017-2022) & ($ Millions)

Figure 15. Viral Gene Therapy in Ophthalmologic Diseases

Figure 16. Global Viral Gene Therapy Market: Ophthalmologic Diseases (2017-2022) & ($ Millions)

Figure 17. Viral Gene Therapy in Infectious Diseases

Figure 18. Global Viral Gene Therapy Market: Infectious Diseases (2017-2022) & ($ Millions)

Figure 19. Viral Gene Therapy in Others

Figure 20. Global Viral Gene Therapy Market: Others (2017-2022) & ($ Millions)

Figure 21. Global Viral Gene Therapy Market Size Market Share by Application in 2021

Figure 22. Global Viral Gene Therapy Revenue Market Share by Player in 2021

Figure 23. Global Viral Gene Therapy Market Size Market Share by Regions (2017-2022)

Figure 24. Americas Viral Gene Therapy Market Size 2017-2022 ($ Millions)

Figure 25. APAC Viral Gene Therapy Market Size 2017-2022 ($ Millions)

Figure 26. Europe Viral Gene Therapy Market Size 2017-2022 ($ Millions)

Figure 27. Middle East & Africa Viral Gene Therapy Market Size 2017-2022 ($ Millions)

Figure 28. Americas Viral Gene Therapy Value Market Share by Country in 2021

Figure 29. Americas Viral Gene Therapy Consumption Market Share by Type in 2021

Figure 30. Americas Viral Gene Therapy Market Size Market Share by Application in 2021

Figure 31. United States Viral Gene Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 32. Canada Viral Gene Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 33. Mexico Viral Gene Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 34. Brazil Viral Gene Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 35. APAC Viral Gene Therapy Market Size Market Share by Region in 2021

Figure 36. APAC Viral Gene Therapy Market Size Market Share by Application in 2021

Figure 37. China Viral Gene Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 38. Japan Viral Gene Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 39. Korea Viral Gene Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 40. Southeast Asia Viral Gene Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 41. India Viral Gene Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 42. Australia Viral Gene Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 43. Europe Viral Gene Therapy Market Size Market Share by Country in 2021

Figure 44. Europe Viral Gene Therapy Market Size Market Share by Type in 2021

Figure 45. Europe Viral Gene Therapy Market Size Market Share by Application in 2021

Figure 46. Germany Viral Gene Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 47. France Viral Gene Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 48. UK Viral Gene Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 49. Italy Viral Gene Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 50. Russia Viral Gene Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 51. Middle East & Africa Viral Gene Therapy Market Size Market Share by Region in 2021

Figure 52. Middle East & Africa Viral Gene Therapy Market Size Market Share by Type in 2021

Figure 53. Middle East & Africa Viral Gene Therapy Market Size Market Share by Application in 2021

Figure 54. Egypt Viral Gene Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 55. South Africa Viral Gene Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 56. Israel Viral Gene Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 57. Turkey Viral Gene Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 58. GCC Country Viral Gene Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 59. Americas Viral Gene Therapy Market Size 2023-2028 ($ Millions)

Figure 60. APAC Viral Gene Therapy Market Size 2023-2028 ($ Millions)

Figure 61. Europe Viral Gene Therapy Market Size 2023-2028 ($ Millions)

Figure 62. Middle East & Africa Viral Gene Therapy Market Size 2023-2028 ($ Millions)

Figure 63. United States Viral Gene Therapy Market Size 2023-2028 ($ Millions)

Figure 64. Canada Viral Gene Therapy Market Size 2023-2028 ($ Millions)

Figure 65. Mexico Viral Gene Therapy Market Size 2023-2028 ($ Millions)

Figure 66. Brazil Viral Gene Therapy Market Size 2023-2028 ($ Millions)

Figure 67. China Viral Gene Therapy Market Size 2023-2028 ($ Millions)

Figure 68. Japan Viral Gene Therapy Market Size 2023-2028 ($ Millions)

Figure 69. Korea Viral Gene Therapy Market Size 2023-2028 ($ Millions)

Figure 70. Southeast Asia Viral Gene Therapy Market Size 2023-2028 ($ Millions)

Figure 71. India Viral Gene Therapy Market Size 2023-2028 ($ Millions)

Figure 72. Australia Viral Gene Therapy Market Size 2023-2028 ($ Millions)

Figure 73. Germany Viral Gene Therapy Market Size 2023-2028 ($ Millions)

Figure 74. France Viral Gene Therapy Market Size 2023-2028 ($ Millions)

Figure 75. UK Viral Gene Therapy Market Size 2023-2028 ($ Millions)

Figure 76. Italy Viral Gene Therapy Market Size 2023-2028 ($ Millions)

Figure 77. Russia Viral Gene Therapy Market Size 2023-2028 ($ Millions)

Figure 78. Spain Viral Gene Therapy Market Size 2023-2028 ($ Millions)

Figure 79. Egypt Viral Gene Therapy Market Size 2023-2028 ($ Millions)

Figure 80. South Africa Viral Gene Therapy Market Size 2023-2028 ($ Millions)

Figure 81. Israel Viral Gene Therapy Market Size 2023-2028 ($ Millions)

Figure 82. Turkey Viral Gene Therapy Market Size 2023-2028 ($ Millions)

Figure 83. GCC Countries Viral Gene Therapy Market Size 2023-2028 ($ Millions)